Novo Nordisk halts work on cell therapy for diabetes to cut costs, Bloomberg News reports
Oct 10, 2025 9:13 AM
(Reuters) -Novo Nordisk has cut its cell therapy division, which has been trying to find a cure for type 1 diabetes, Bloomberg News reported on Friday, citing a statement.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.